Company / Inventory per Share
UroGen Pharma Ltd. Inventory per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$0.39
FY2025
5-year range
$0.19 / $0.39
FY2021-FY2025
Trend
+37.3%
vs FY2024
Sector context
#64 of 105
Health Care
What the data says
At $0.39, UroGen Pharma Ltd.'s inventory per share ranks #64 of 105 in the Health Care sector. Inventory per Share has increased for 3 consecutive years, from $0.19 in FY2022 to $0.39 in FY2025.
Based on SEC 10-K filings.
0.39 in FY2025 with a 5-year CAGR of +33.1%.
Improved from $0.25 to $0.39 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +26.5%
- 5-Year CAGR
- +33.1%
- 10-Year CAGR
- -
Sector benchmark
#64 of 105 in Health CareTop 61% of 105This company $0.39 Sector average $30.82
▼
-98.7% below sector average
Key checks
Key Insights
- UroGen Pharma Ltd.'s inventory per share has grown for 3 consecutive years.
- In FY2025, inventory per share increased 37.3% year-over-year.
- Ranks #64 out of 105 companies in the Health Care sector.
- Lowest inventory per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.39 | +37.3% |
| FY2024 | $0.28 | +15.8% |
| FY2023 | $0.25 | +27.4% |
| FY2022 | $0.19 | -11.7% |
| FY2021 | $0.22 | +133.4% |
| FY2020 | $0.09 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $0.03 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026